myelodysplastic syndromes - Globe Thesis

Keyword [myelodysplastic syndromes] Result: 181 - 200 \| Page: 10 of 10
181.	Haploid Allogeneic Hematopoietic Stem Cell Transplantation For Myelodysplastic Syndrome
182.	The Prognostic Impact Of Mutation Status And Burden In Lower-risk Myelodysplastic Syndromes
183.	Correlation Between Molecular Genetics And Clinical Features Of 77 Patients With Myelodysplastic Syndromes
184.	4-Amino-2-Trifluoromethyl-Phenyl Retinate Induced Differentiation Of Human Myelodysplastic Syndromes SKM-1 Cell Lines By Up-Regulating DDX23
185.	Effect Of Compound Shenlu Granules On Apoptosis Of Bone Marrow CD34~+ Cells In Lower-risk MDS With Kidney-Yang Deficiency By Inhibiting P38MAPK Phosphorylation
186.	4SC-202 Induces Apoptosis In Myelodysplastic Syndromes And The Underlying Mechanism
187.	Clinical Features Of Myelodysplastic Syndromes Patients With Autoimmune Disorders
188.	Professor Jiang Wenming's Clinical Experience In Treating Myelodysplastic Syndrome
189.	Clinical Study Of Yisui Granule In The Treatment Of 48 Patients With Low- And Intermediate-risk Myelodysplastic Syndromes
190.	Data Mining And Analysis Of The Characteristic Data Of Professor Liu Baowen's Medication For The Treatment Of Myelodysplastic Syndrome
191.	Clinical Study Of Yisuifang Combined With EPO/low-dose Decitabine In The Treatment Of Myelodysplastic Syndrome
192.	Characterization of the Myelodysplastic Syndromes-Related SRSF2 P95 Mutation
193.	Chromosomal mapping of genes encoding human Pur-alpha and Pur-beta: Independent and simultaneous deletions in myelodysplastic syndromes and acute myelogenous leukemia
194.	Role Of TIM3/Gal-9 Signaling Pathway In Cellular Immune Tolerance Of The Patients With Myelodysplastic Syndromes
195.	Part 1 Features And Clinical Significance Of Gene Mutations In Patients With Myelodysplastic Syndromes With Ring Sideroblasts Part 2 Origination Of Myofibroblasts And Fibrocytes In Persons With Primary Myelofibrosis And Persons With Myelodysplastic Syndro
196.	Concurrence Of Myelodysplastic Syndromes And Large Granular Lymphocyte Leukemia:Clinicopathological Features,Mutational Profile And Whole-Exome Sequencing Analysis In A Single Center
197.	Investigation On The Abnormal Osteogenic Differentiation Of Bone Marrow Mesenchymal Stromal Cells In Myelodysplastic Syndromes
198.	Cellular Senescence Induced By S100A9 In Mesenchymal Stromal Cells Through NLRP3 Inflammasome Activation In Myelodysplastic Syndromes
199.	Study On The Efficacy Of Decitabine For The Treatment Of R/R-AML And MDS And The Mechanism Of DUSP16 In Children With AML
200.	Clinical Efficacy Of Low-dose Decitabine Combined With Cytarabine In The Treatment Of Patients With High-risk MDS
<<First <Prev Next> Last>> Jump to